IL16 and cervical cancer: Here, we provide the first evidence that rs1131445 in the miR-135b binding site of IL-16 3′-UTR, which can affect IL-16 protein expression by interfering with miR135b suppressive function, was significantly associated with the risk of cervical cancer.